Insider Sell: Arcellx Inc's Chief Medical Officer Christopher Heery Disposes of 46,815 Shares

Arcellx Inc (NASDAQ:ACLX), a clinical-stage biopharmaceutical company focusing on the development of novel cell-based cancer therapies, has reported an insider sell according to the latest SEC filings.

Related Keywords

,Arcellx Inc ,